Botox Microinfusion

Botox microinfusion, the most popular injectable treatment in South Korea, is used to achieve the “glass skin” with the look of smaller pores, increased elasticity, and diminished flushing. First developed in Singapore, and also known as “mesobotox” or “microbotox” this is not the traditional type of Botox treatment common in the U.S. that relaxes muscles to soften expression lines. Rather, Dr. Sherber will make a dilute sterile solution of BotoxⓇ Cosmetic and stamp it into the dermis - the skin's collagen layer - with tiny hollow needles rather than injecting into the muscles. This is a full-face treatment, and depending on where the Botox microinfusion is concentrated you can achieve diminished oil production and smaller pores, improvement in skin redness, and increased elasticity.

Dr. Sherber is an expert on Botox microinfusion, and was invited to be an author on the first international consensus paper for best practices in microbotox treatment alongside colleagues from around the world. This treatment is especially popular with our patients before big events or appearances on camera. For those who would like an extra hydration boost, we can mix in Skinvive. As cited in the Washington Post: “Optimal treatments for those who are frequently on television focus on skin quality,” says Washington dermatologist Noëlle Sherber… She has several patients — elected officials, CEOs, and others in the public eye — who start “prejuvenation” treatments in their 30s and 40s. ‘So that by the time they reach their 70s,” she says, “they look like they’re still in their 50s.’” Dr. Sherber was named Washington DC’s best for Botox in Allure magazine: “D.C. women who’ve tried doctor after doctor for Botox keep coming back to this one.” She also serves as an Advisory Board member to help develop best practices and innovation for Allergan Aesthetics (the manufacturer of Botox®). Dr. Sherber has published research on differential Botox dosing across patient ages, and on evidence-based approaches to microbotox for skin quality treatment. She is a Principle Investigator in the FDA Phase III clinical trial of Botox for masseter muscle prominence, also known as “jawline” Botox, to relax masseter muscles to achieve a slimmer facial structure.